Previous Page  210-211 / 2001 Next Page
Information
Show Menu
Previous Page 210-211 / 2001 Next Page
Page Background

Most available data thus strongly

suggest that at least a subset of

selected patients in the

intermediate-risk group may benefit

from Brachytherapy as

monotherapy …